b x0c x0c x0c x0c x0c x0co o o o o o o o o x0c x0co o o o o o o o o o x0c x0ca x0cb x0c x0c x0c x0c x0c x0co o x0co o x0co xef x82 xa7 support feasibility studies affording analysis patient populations study sites clinical trial design information clinical trial study parameters adjusted maximize trial xe2 x80 x99s speed cost effectiveness xef x82 xa7 help establish patient cohorts inclusion exclusion criteria support clinical trial optimization drugs designed target specific molecular pathway gene variant omics data provide valuable information guide selection patients study cohorts xef x82 xa7 provide insight classify clinical trial population based molecular signatures ensure targeted inclusion exclusion criteria x0cwhich lead smaller study populations reducing costs dramatically xef x82 xa7 enable adaptive clinical trials characterizing study cohorts providing insights drug safety efficacy information determine pharmacogenomic effects support modifications drug dosage patient inclusion criteria clinical trial sample size o patient recruitment estimates patient enrollment clinical trials responsible 30% time takes conduct clinical trials sites enroll patients shivom xe2 x80 x99s databases potential dramatically improve recruitment process connecting patients trials anonymous fashion pharmaceutical cro organizations access treasure trove information potential participants users associated investigative sites likely motivated join study o data quality reproducibility multiple reports studies fueling discussions reproducibility results especially biomedical sciences discussions raise concerns level trust results scientific literature public databases organizations clinical studies shivom genomics ecosystem updated new data curated quality records compliant local regulations genomic data handling essential maintain integrity provenance security privacy sensitive information processes data uploading processing analysis sharing systematizing process essential shivom dynamically accommodate manage changes workflow x0c x0c x0co o o o o x0c x0co o o o x0co o o o o o o x0co o o o o o o o o o o o o o o o o o o o o x0co o o x0co o o o o o x0c x0co o x0co o xef x82 xa7 xef x82 xa7 xef x82 xa7 xef x82 xa7 xef x82 xa7 o xef x82 xa7 x0c xef x82 xa7 xef x82 xa7 o o x0cglobal alliance genomics health pistoia alliance cdisc ebi ontology service x0c x0c x0c x0c x0cc o o o x0co x0co o xef x82 xa7 xef x82 xa7 x0c xef x82 xa7 o o x0co o x0cd d x0co o o o o o o o o o o o o o o o o o o o o o o o o o o o x0co o x0chere x0c x0caxel schumacher phd co founder ceo gourish singla co founder coo sally eaves phd co founder cmo x0cakash gaurav co founder cto henry l ines chief innovation officer natalie pankova phd chief scientific officer agam kansal marketing lead x0cdr rashad ibrahim middle east head stephane laurent chinese subcontinent head pierre maarek investment lead charles leslie investment lead kayleen schreiber phd design lead x0cting peng pr manager azam shaghaghi head public relations ajit singh kular head digital marketing x0cdr jay sanders antanas guoga david orban geoff hancock x0cdr william yasnoff dr irshaad ebrahim dr kamala k maddali x0c1 x0c x0c x0c